CD8A and neoplasm: Zhang et al. found that CD19+ EVs from B cells contain high levels of CD39 and CD73, which hydrolyze the ATP released by tumor cells after chemotherapy into adenosine and attenuate the effect of chemotherapy by inhibiting the CD8+ T cell response (125).